Akcea Therapeutics

Pfizer-licensed Cardiovascular Drug Reduces Triglycerides in Phase II
BioSpace
Fri, 11/26/21 - 08:49 pm
Akcea Therapeutics
Pfizer
clinical trials
triglycerides
vupanorsen
Ionis and Akcea announce that Pfizer initiated clinical study of vupanorsen
Pharmaceutical Business Review
Wed, 11/4/20 - 10:13 am
Ionis Pharmaceuticals
Akcea Therapeutics
Pfizer
clinical trials
vupanorsen
cholesterol
Ionis strikes deal to buy back lipid disease spinout Akcea
Fierce Biotech
Mon, 08/31/20 - 10:17 am
Ionis Pharmaceuticals
Akcea Therapeutics
M&A
lipid disease
Akcea and Ionis Confirm Positive Trial Results for Hypertriglyceridemia Treatment
Motley Fool
Wed, 01/29/20 - 10:42 am
Akcea Therapeutics
Ionis Pharmaceuticals
hypertriglyceridemia
AKCEA-ANGPTL3-Lrx
clinical trials
These Biotechs Were Focused on One Line on Pfizer’s Earnings Report
Motley Fool
Thu, 10/31/19 - 11:51 pm
Pfizer
Vyndaqel
Alnylam
Akcea Therapeutics
Ionis Pharmaceuticals
Eidos Therapeutics
3 Akcea execs, including CEO, leave in a 'disconcerting surprise'
Biopharma Dive
Mon, 09/23/19 - 11:50 am
Akcea Therapeutics
Can Pfizer Leap Over the Competition With This Potential Blockbuster?
Motley Fool
Wed, 05/8/19 - 10:03 am
Pfizer
Vyndamax
tafamidis
ATTR
Alnylam
Onpattro
Akcea Therapeutics
Tegsedi
Eidos Therapeutics
AG10
Ionis, Akcea succeed in heart drug trial, setting up Novartis decision
Biopharma Dive
Tue, 11/13/18 - 10:13 pm
Akcea Therapeutics
Ionis Pharmaceuticals
clinical trials
Novartis
AKCEA-APO(a)-Lrx
Akcea reducing workforce 10% following Waylivra rejection
Biopharma Dive
Thu, 09/6/18 - 07:26 pm
Akcea Therapeutics
layoffs
Waylivra
FDA rejects Akcea rare-disease drug that uses gene-blocking technology
Stat
Mon, 08/27/18 - 11:00 pm
FDA
Akcea Therapeutics
Waylivra
familial chylomicronemia syndrome
3 Biotech Stocks With Major Catalysts Incoming
Motley Fool
Mon, 08/13/18 - 11:26 am
TG Therapeutics
Sangamo Therapeutics
Akcea Therapeutics
FDA
Waylivra
umbralisib
SB-913
FDA Advisory Committee Votes in Favor of Waylivra for Treatment of Familial Chylomicronemia Syndrome
CP Wire
Fri, 05/11/18 - 10:09 am
Akcea Therapeutics
Ionis Pharmaceuticals
FDA
advisory panel
Waylivra
Volanesorsen
FCS
Outlook for Ionis, Akcea drug marred by safety concerns
Biopharma Dive
Wed, 05/9/18 - 09:25 pm
Ionis Pharmaceuticals
Akcea Therapeutics
FDA
advisory panel
Volanesorsen
FDA Extends Action Date on Akcea's Inotersen, Alnylam Now in Lead
Fri, 05/4/18 - 09:54 am
Akcea Therapeutics
inotersen
Alnylam
Patisiran
3 Small-Cap Biotech Stocks With Big Catalysts in May
Motley Fool
Mon, 04/30/18 - 09:16 pm
Achaogen
plazomicin
Akcea Therapeutics
Volanesorsen
Portola Pharmaceuticals
AndexXa
Isis launches a cardio subsidiary and recruits a Genzyme vet to run it
Fierce Biotech
Wed, 01/7/15 - 08:15 pm
Isis Pharmaceuticals
Genzyme
Akcea Therapeutics